Drug Pipeline

XR-B Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
2
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT06306443
Buprenorphine for Individuals in Jail		 date change Primary completion pushed: 2028-08-31 -> 2029-01-01
2026-05-23 NCT06306443
Buprenorphine for Individuals in Jail		 date change Completion moved earlier: 2029-12-31 -> 2029-04-30
Active Studies by Phase
Phase 3
1
Phase 2/3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06306443 Buprenorphine for Individuals in Jail Opioid Use Disorder Recruiting
Phase 2/3
NCT04408313 Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals… Opioid-use Disorder Active, Not Recruiting
Phase 2
NCT06441604 Extended-release Buprenorphine as a Novel Low-dose Induction Strategy Opioid Use Disorder Recruiting
Sponsors Running XR-B Trials
Friends Research Institute, Inc. (2) Brigham and Women's Hospital (1)
Get alerts when XR-B trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free